Skip to main content
AAN.com
Clinical/Scientific Notes
January 2, 2007
Letter to the Editor

Increased incidence of deep venous thrombosis in ALS

First page of PDF

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (e1.doc)

References

1.
Kniffin Jr W, Baron J, Barrett J, Birkmeyer J, Anderson FA. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994;154:861–866.
2.
Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d’Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000;83:657–660.
3.
Cudkowicz M, Shefner J, Schoenfeld D, et al. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology 2003;61:456–464.
4.
Shefner JM, Cudkowicz ME, Schoenfeld D, et al. A clinical trial of creatine in ALS. Neurology 2004;63:1656–1661.
5.
Cudkowicz M, Shefner J, Schoenfeld D, et al. Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol 2006;60:22–31.
6.
Breslow N, Day N. Statistical Methods in Cancer Research. Lyon: International Agency for Research on Cancer, 1987.
7.
Elman LB, Siderowf A, Houseman G, Kelley M, McCluskey LF. Venous thrombosis in an ALS population over four years. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:246–249.
Letters to the Editor
14 March 2007
Increased incidence of deep venous thrombosis in ALS
Fumiharu Kimura, Osaka Medical College
I read with great interest the article by Qureshi et al who describe an increased incidence of deep venous thrombosis (DVT) in ALS patients with an annual incidence rate of 2.7% and acute pulmonary thromboembolism (PE) in 1.6% of patients. [1] The higher incidence of DVT was observed in ALS patients with greater immobility and lower respiratory function.

I agree that the real incidence of DVT in ALS patients is underestimated, particularly when considering the following conditions of ALS: muscular weakness and atrophy in the legs leads to decreased muscle- pump activity which facilitates blood congestion; reduced fluid intake in ALS with bulbar palsy may induce dehydration and thrombosis; and hypoxemia leads to endothelial cell damage, the production of oxygen-derived free radicals, and venous wall relaxation--causing decreased flow velocity and stasis.

We reported the case of a 61-year-old man with ALS who developed acute respiratory failure from PE which can masquerade as respiratory failure due to progression of ALS. [2] The key in the diagnosis of PE was the blood gas findings for hypoxemia and hypocapnia at admission, which were incompatible with the type II respiratory failure seen in the terminal stage of ALS.

This patient regularly worked for 8 hours in a sitting position using his small wheelchair. Deep-vein echography disclosed marked thrombosis in the right popliteal vein, suggesting that popliteal vein entrapment is a complication of using small wheelchairs with greater restrictions of joint movement. Venous stasis from extended sitting in the wheelchair may enhance the formation of DVT and subsequent PE similar to Economy Class Syndrome which describes air travel-related DVT and PE due to the compression of vessel lesions while sitting in a cramped position during long-distance flights with low aircraft cabin oxygen pressure. [3]

Long-term use of wheelchairs may be related to the occurrences of DVT and PE. Is it possible that patients with DVT and/or PE who had lower %VC and lower leg strength were wheelchair users? In addition, was DVT located in the proximal or distal portion of the popliteal vein in these cases?

The frequency of DVT for individuals undergoing stroke rehabilitation is higher in wheelchair-bound patients than in bedridden patients. [4] From a public health standpoint, Wheelchair Economy Class Syndrome offers a warning not only for long-term wheelchair users with ALS, but also for other immobile patients.

References

1. Qureshi MM, Cudkowicz ME, Zhang H, Raynor E. Increased incidence of deep venous thrombosis in ALS. Neurology 2007 68: 76-77.

2. Kimura F, Ishida S, Furutama D, et al. Wheelchair Economy Class Syndrome in Amyotrophic Lateral Sclerosis. Neuromuscul Disord 2006 16:204-207.

3. Symington LS, Bryan RS. Pulmonary thromboembolism after travel. Br J Dis Chest 1977 71:138-140.

4. Oczkowski WJ, Ginsberg JS, Shin A, Panju A. Venous thromboembolism in patients undergoing rehabilitation for stroke. Arch Phys Med Rehabil 1992 73:712-716.

Disclosure: The author reports no conflicts of interest.

14 March 2007
Reply from the Authors
Muddasir Qureshi, Massachusetts General Hospital
Merit Cudkowicz, Hui Zhang, Elizabeth Raynor

We thank Dr. Kimura for his correspondence regarding our article. [1] We read his paper [2] and have re-analyzed our data to address the queries. The walking scores for the Ayotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) of the eleven ALS patients, who suffered from DVT, revealed the following walking status at the time of enrollment into the trials (baseline visit):

Non-ambulatory functional movement - two patients

Early ambulation difficulties - three patients

Walks with assistance - five patients

Normal - one patient

It can be postulated that the patients with ALS who suffered from DVT were likely to be immobile at baseline and may have ambulated using wheelchairs. However, we do not have specific data regarding wheelchair usage or ultrasound findings in these patients.

References: The authors report no conflicts of interest.

Information & Authors

Information

Published In

Neurology®
Volume 68Number 1January 2, 2007
Pages: 76-77
PubMed: 17200499

Publication History

Published online: January 2, 2007
Published in print: January 2, 2007

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

M. Muddasir Qureshi, MD, MPH
From the Neurology Clinical Trials Unit (M.M.Q., M.E.C.), Department of Neurology, Biostatistics Center (H.Z.), Massachusetts General Hospital, Beth Israel Deaconess Medical Center (E.R.), Harvard Medical School, Boston, MA.
Merit E. Cudkowicz, MD, MSc
From the Neurology Clinical Trials Unit (M.M.Q., M.E.C.), Department of Neurology, Biostatistics Center (H.Z.), Massachusetts General Hospital, Beth Israel Deaconess Medical Center (E.R.), Harvard Medical School, Boston, MA.
Hui Zhang, MS
From the Neurology Clinical Trials Unit (M.M.Q., M.E.C.), Department of Neurology, Biostatistics Center (H.Z.), Massachusetts General Hospital, Beth Israel Deaconess Medical Center (E.R.), Harvard Medical School, Boston, MA.
Elizabeth Raynor, MD
From the Neurology Clinical Trials Unit (M.M.Q., M.E.C.), Department of Neurology, Biostatistics Center (H.Z.), Massachusetts General Hospital, Beth Israel Deaconess Medical Center (E.R.), Harvard Medical School, Boston, MA.

Notes

Address correspondence and reprint requests to Dr. Muddasir Qureshi, Department of Neurology, Massachusetts General Hospital, East, Building 149, 13th Street, Room No. 2274, Charlestown, MA 02129; e-mail: [email protected] or [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Venous thromboembolism risk in amyotrophic lateral sclerosis: a hospital record-linkage study, Journal of Neurology, Neurosurgery & Psychiatry, (jnnp-2024-333399), (2024).https://doi.org/10.1136/jnnp-2024-333399
    Crossref
  2. Venous thromboembolism and amyotrophic lateral sclerosis: the Venous Thrombo-Embolism and Sclerosis Lateral Amyotrophic study, Research and Practice in Thrombosis and Haemostasis, 8, 1, (102287), (2024).https://doi.org/10.1016/j.rpth.2023.102287
    Crossref
  3. Deep vein thrombosis and its risk factors in neurodegenerative diseases: A markedly higher incidence in Parkinson's disease, Journal of the Neurological Sciences, 457, (122896), (2024).https://doi.org/10.1016/j.jns.2024.122896
    Crossref
  4. Phlebology Implications in Amyotrophic Lateral Sclerosis, Neurology Clinical Practice, 13, 1, (2023)./doi/10.1212/CPJ.0000000000200128
    Abstract
  5. Increased Risk of Venous Thromboembolism in Patients With Amyotrophic Lateral Sclerosis, Neurology Clinical Practice, 13, 1, (2023)./doi/10.1212/CPJ.0000000000200110
    Abstract
  6. Emergencies in Motor Neuron Diseases, Emergencies in Neuromuscular Disorders, (155-180), (2022).https://doi.org/10.1007/978-3-030-91932-0_6
    Crossref
  7. Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study, Brain Communications, 2, 2, (2020).https://doi.org/10.1093/braincomms/fcaa160
    Crossref
  8. Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21, 1-2, (15-23), (2019).https://doi.org/10.1080/21678421.2019.1672750
    Crossref
  9. Critical Care of Neuromuscular Disorders, CONTINUUM: Lifelong Learning in Neurology, 24, 6, (1753-1775), (2018).https://doi.org/10.1212/CON.0000000000000682
    Crossref
  10. Amyotrophic lateral sclerosis, Nature Reviews Disease Primers, 3, 1, (2017).https://doi.org/10.1038/nrdp.2017.71
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share